SABCS 2010: Interview with Eric P. Winer, M.D., director of the Breast Oncology Center and Thompson senior investigator in breast cancer research at Dana-Farber Cancer Institute; professor of Medicine at Harvard Medical School Dr. Winer discusses breast cancer screening, the clinical...
Dr. Coleman, chief investigator of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial, presents the rationale for studying the bisphosphonate zoledronic acid, and the final results of this study.
Dr. Workman defines molecular chaperones and discusses their role in the cell, stress response pathways, heat shock proteins and the potential of this line of breast cancer research.
Dr. Chlebowski, lead investigator for the Women's Health Initiative, discusses the initiative's findings about the use of hormone therapy and its influence on cancer incidence and related cancer mortality, and the effects of bisphosphonates on breast cancer risk.
Dr. Esserman discusses her philosophy of holistic treatment and involving patients in the decision-making process, a cancer risk tracking system, and the I-Spy trials that match treatments to patients based on biomarkers.
Dr. Pantel discusses his findings about micrometastasis that contradict long-held beliefs about metastasis, and the implications of these discoveries for the treatment of breast cancer.
In this podcast, Dr. Perez discusses ALTTO (the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), the role of genetic markers in breast cancer treatment, the challenges of treating patients with triple-negative breast cancer, and the promise of personalized medicine.
Dr. Perou talks about genomic and genetic approaches to characterizing diverse breast cancers and their unique biologic features, using next-generation sequencing, and the implications of this science for clinical use.
Ms. Shoretz talks about the mission of Sharsheret, how she came to establish this nonprofit organization, and her appointment to a federal advisory committee on breast cancer in young women.
Ms. Stanford talks about the mission of the Alamo Breast Cancer Foundation and how advocates can take an active role in breast cancer research.
Neil Spector, M.D., professor of medicine at Duke University Medical Center, hosts this press conference.
Minetta Liu, M.D., director of translational breast cancer research at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, hosts this press conference.
The government will not contest an appeals court ruling that investigators illegally seized a list of baseball players who allegedly tested positive for steroids, the Justice Department said Friday. That decision keeps intact a legal victory for scores of ballplayers snared in the doping...
The FDA’s Dental Products Panel will be asked this week to consider what scientific methodology is needed to determine unsafe levels of dental amalgam and mercury, especially for children and other vulnerable patients.
As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the...